Advertisement

Topics

Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program

11:56 EST 20 Nov 2018 | Investing News Network

Auris Medical (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health supportive care, today announced the results of its pre-Investigational New Drug (pre-IND) meeting with the United States Food & Drug Administration (FDA), where the FDA addressed the Company’s questions and provided guidance on its … Continued

The post Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program appeared first on Investing News Network.

Original Article: Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program

NEXT ARTICLE

More From BioPortfolio on "Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...